Cargando…

Role of IL-24 in the mucosal remodeling of children with coeliac disease

BACKGROUND: Recently, involvement of IL-19, IL-20 and IL-24 has been reported in inflammatory diseases associated with tissue remodeling. However, their impact on the pathomechanism of coeliac disease (CD) is still completely unknown. METHODS: Expression of IL19, IL20 and IL24 was measured by real-t...

Descripción completa

Detalles Bibliográficos
Autores principales: Rokonay, Réka, Veres-Székely, Apor, Szebeni, Beáta, Pap, Domonkos, Lippai, Rita, Béres, Nóra J., Veres, Gábor, Szabó, Attila J., Vannay, Ádám
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977354/
https://www.ncbi.nlm.nih.gov/pubmed/31973719
http://dx.doi.org/10.1186/s12967-020-02221-2
_version_ 1783490491476606976
author Rokonay, Réka
Veres-Székely, Apor
Szebeni, Beáta
Pap, Domonkos
Lippai, Rita
Béres, Nóra J.
Veres, Gábor
Szabó, Attila J.
Vannay, Ádám
author_facet Rokonay, Réka
Veres-Székely, Apor
Szebeni, Beáta
Pap, Domonkos
Lippai, Rita
Béres, Nóra J.
Veres, Gábor
Szabó, Attila J.
Vannay, Ádám
author_sort Rokonay, Réka
collection PubMed
description BACKGROUND: Recently, involvement of IL-19, IL-20 and IL-24 has been reported in inflammatory diseases associated with tissue remodeling. However, their impact on the pathomechanism of coeliac disease (CD) is still completely unknown. METHODS: Expression of IL19, IL20 and IL24 was measured by real-time RT-PCR, protein amount of IL-24, α smooth muscle actin (α-SMA) and fibronectin (FN) was determined by Western-blot analysis in the duodenal biopsies of therapy naive children with CD and controls. Localization of IL-24 and IL-20RB was investigated by immunofluorescent staining in the duodenal mucosa. Effect of recombinant IL-1β, TNF-α, TGF-β and IL-17 treatment on the expression of IL19, IL20, IL24 and their receptors was investigated by real-time RT-PCR in small intestinal epithelial cells (FHs74Int), in primary duodenal myofibroblasts (pdMFs) and in peripheral blood mononuclear cells (PBMCs). Effect of IL-24 on H(2)O(2) treated FHs74Int cells and on pdMFs was measured by MTT, LDH, Annexin V assays, real-time RT-PCR and by fluorescent microscopy. RESULTS: We found increased level of IL-24 (3.3×, p < 0.05), α-SMA (2.4×, p < 0.05) and FN (2.3×, p < 0.05) in the duodenal mucosa and increased expression of IL19 (3.6×, p < 0.05) and IL24 (5.2×, p < 0.05) in the PBMCs of children with CD compared to that of controls. IL-1β was a strong inducer of IL24 expression of FHs74Int cells (9.9×, p < 0.05), pdMFs (552.9×, p < 0.05) or PBMCs (17.2×, p < 0.05), as well. IL-24 treatment reduced the number of apoptotic cells (0.5×, p < 0.05) and decreased the expression of inflammatory factors, including IL1A, IL6 and TNF of H(2)O(2)-treated FHs74Int cells. IL-24 decreased the proliferation (0.6×, p < 0.05) of PDGF-B treated pdMFs. Moreover, IL-24 treatment altered the morphology of pdMFs by influencing the size of the angles between stress fibers and the longitudinal axis of the cells (2.0×, p < 0.05) and the expression of cytoskeletal components, including ACTA2, ACTB, VIM, SNAI1 and SNAI2. CONCLUSION: Our results suggest that IL-24 plays a significant role in the maintenance of duodenal mucosal integrity in CD.
format Online
Article
Text
id pubmed-6977354
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-69773542020-01-28 Role of IL-24 in the mucosal remodeling of children with coeliac disease Rokonay, Réka Veres-Székely, Apor Szebeni, Beáta Pap, Domonkos Lippai, Rita Béres, Nóra J. Veres, Gábor Szabó, Attila J. Vannay, Ádám J Transl Med Research BACKGROUND: Recently, involvement of IL-19, IL-20 and IL-24 has been reported in inflammatory diseases associated with tissue remodeling. However, their impact on the pathomechanism of coeliac disease (CD) is still completely unknown. METHODS: Expression of IL19, IL20 and IL24 was measured by real-time RT-PCR, protein amount of IL-24, α smooth muscle actin (α-SMA) and fibronectin (FN) was determined by Western-blot analysis in the duodenal biopsies of therapy naive children with CD and controls. Localization of IL-24 and IL-20RB was investigated by immunofluorescent staining in the duodenal mucosa. Effect of recombinant IL-1β, TNF-α, TGF-β and IL-17 treatment on the expression of IL19, IL20, IL24 and their receptors was investigated by real-time RT-PCR in small intestinal epithelial cells (FHs74Int), in primary duodenal myofibroblasts (pdMFs) and in peripheral blood mononuclear cells (PBMCs). Effect of IL-24 on H(2)O(2) treated FHs74Int cells and on pdMFs was measured by MTT, LDH, Annexin V assays, real-time RT-PCR and by fluorescent microscopy. RESULTS: We found increased level of IL-24 (3.3×, p < 0.05), α-SMA (2.4×, p < 0.05) and FN (2.3×, p < 0.05) in the duodenal mucosa and increased expression of IL19 (3.6×, p < 0.05) and IL24 (5.2×, p < 0.05) in the PBMCs of children with CD compared to that of controls. IL-1β was a strong inducer of IL24 expression of FHs74Int cells (9.9×, p < 0.05), pdMFs (552.9×, p < 0.05) or PBMCs (17.2×, p < 0.05), as well. IL-24 treatment reduced the number of apoptotic cells (0.5×, p < 0.05) and decreased the expression of inflammatory factors, including IL1A, IL6 and TNF of H(2)O(2)-treated FHs74Int cells. IL-24 decreased the proliferation (0.6×, p < 0.05) of PDGF-B treated pdMFs. Moreover, IL-24 treatment altered the morphology of pdMFs by influencing the size of the angles between stress fibers and the longitudinal axis of the cells (2.0×, p < 0.05) and the expression of cytoskeletal components, including ACTA2, ACTB, VIM, SNAI1 and SNAI2. CONCLUSION: Our results suggest that IL-24 plays a significant role in the maintenance of duodenal mucosal integrity in CD. BioMed Central 2020-01-23 /pmc/articles/PMC6977354/ /pubmed/31973719 http://dx.doi.org/10.1186/s12967-020-02221-2 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Rokonay, Réka
Veres-Székely, Apor
Szebeni, Beáta
Pap, Domonkos
Lippai, Rita
Béres, Nóra J.
Veres, Gábor
Szabó, Attila J.
Vannay, Ádám
Role of IL-24 in the mucosal remodeling of children with coeliac disease
title Role of IL-24 in the mucosal remodeling of children with coeliac disease
title_full Role of IL-24 in the mucosal remodeling of children with coeliac disease
title_fullStr Role of IL-24 in the mucosal remodeling of children with coeliac disease
title_full_unstemmed Role of IL-24 in the mucosal remodeling of children with coeliac disease
title_short Role of IL-24 in the mucosal remodeling of children with coeliac disease
title_sort role of il-24 in the mucosal remodeling of children with coeliac disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977354/
https://www.ncbi.nlm.nih.gov/pubmed/31973719
http://dx.doi.org/10.1186/s12967-020-02221-2
work_keys_str_mv AT rokonayreka roleofil24inthemucosalremodelingofchildrenwithcoeliacdisease
AT veresszekelyapor roleofil24inthemucosalremodelingofchildrenwithcoeliacdisease
AT szebenibeata roleofil24inthemucosalremodelingofchildrenwithcoeliacdisease
AT papdomonkos roleofil24inthemucosalremodelingofchildrenwithcoeliacdisease
AT lippairita roleofil24inthemucosalremodelingofchildrenwithcoeliacdisease
AT beresnoraj roleofil24inthemucosalremodelingofchildrenwithcoeliacdisease
AT veresgabor roleofil24inthemucosalremodelingofchildrenwithcoeliacdisease
AT szaboattilaj roleofil24inthemucosalremodelingofchildrenwithcoeliacdisease
AT vannayadam roleofil24inthemucosalremodelingofchildrenwithcoeliacdisease